Project Grant R61AA031291
Award Date
9/25/24
Completion Date
8/31/26
Dollars Obligated
$725K
Federal Agency
National Institute on Alcohol Abuse and Alcoholism
Federal Grant Program
93.273
Assistance Type
Project Grant
Place of Performance
California, USA
Similar Awards
The National Institute on Alcohol Abuse and Alcoholism (NIAAA) has awarded a $265,510 Project Grant under the Alcohol Research Programs (CFDA 93.273) to the University of California, Los Angeles (UCLA) to conduct a clinical trial evaluating the use of Trigeminal Nerve Stimulation (TNS) for treating prenatal alcohol exposure (PAE). The R61/R33 grant will first determine the feasibility and safety of using TNS, a noninvasive neurostimulatory therapy, to address the debilitating behavioral symptoms...
This federal Project Grant award from the National Institute on Alcohol Abuse and Alcoholism (NIAAA), under the Alcohol Research Programs (CFDA 93.273), provides $317,534.10 to the University of North Carolina at Chapel Hill to conduct research on maternal-fetal metabolic disruption in prenatal alcohol exposure. The goal is to gain mechanistic insight into the basis for fetal growth deficits associated with fetal alcohol spectrum disorders (FASD), focusing on how alcohol prevents the mother from...
The National Institute on Alcohol Abuse and Alcoholism (NIAAA) awarded a $499,987 Project Grant (CFDA 93.273 - Alcohol Research Programs) to CFD Research Corporation, a small for-profit engineering and technology firm based in Huntsville, Alabama. The grant will be used to develop a High Throughput Alcohol Screening Platform (HT-ASP) that incorporates vascularized cortical organoids as a living biological sensor platform. The goal is to create a highly robust and genetically diverse platform for...
The National Institute on Alcohol Abuse and Alcoholism (NIAAA) awarded a $412,125 Project Grant under the Alcohol Research Programs (CFDA 93.273) to The Research Foundation For The State University Of New York to study the impact of prenatal alcohol and methadone exposure on the regulation of dopamine signaling and synaptic plasticity in the basolateral amygdala. The two-year project aims to determine how the combined exposure to prenatal alcohol and methadone alters social and non-social...
The National Institute on Alcohol Abuse and Alcoholism (NIAAA) awarded a $438,375 Project Grant under the Alcohol Research Programs (CFDA 93.273) to Cedars-Sinai Medical Center to establish a human liver-on-a-chip model for studying alcohol-associated liver disease (ALD). The 2-year project, starting September 2023, aims to investigate the roles of liver sinusoidal endothelial cells and acetaldehyde metabolism in regulating ethanol-induced liver damage as well as the contribution of fibrotic...
This federal Project Grant award, with an ID of K99AA031508, was provided by the National Institute on Alcohol Abuse and Alcoholism (NIAAA) under the Alcohol Research Programs (CFDA 93.273) federal grant program. The award totals $174,067 and covers the period from September 1, 2024 to August 30, 2026. The primary objective of this grant is to develop and evaluate a novel Transcranial Magnetic Stimulation (TMS) treatment approach, called Functional Connectivity-Guided TMS (FCG-TMS), for...
This federal Project Grant award from the National Institute on Alcohol Abuse and Alcoholism (NIAAA), under the Alcohol Research Programs (CFDA 93.273) federal grant program, will support research into the neuroepigenetic mechanisms underlying the transgenerational effects of alcohol exposure. The overarching goal is to reveal the fundamental genetic and epigenetic programs that encode and transmit the effects of alcohol exposure across multiple generations. The awarded $148,568 will fund...
This $673,500 Project Grant from the National Institutes of Health's National Institute on Alcohol Abuse and Alcoholism will fund Amygdala Neurosciences, Inc. to develop new, potent, selective, and reversible inhibitors of aldehyde dehydrogenase 2 (ALDH2) for the treatment of alcohol use disorder. The goal is to implement an innovative screening technology to discover novel compounds that reduce craving and alcohol consumption by selectively inhibiting ALDH2 in a reversible manner, avoiding...
This $349,738 project grant award from the National Institute on Alcohol Abuse and Alcoholism (NIAAA) under the Alcohol Research Programs (CFDA 93.273) is funding research at Ursinus College to investigate the role of microglial fractalkine signaling in altered dopaminergic wiring resulting from fetal alcohol spectrum disorders (FASD). The research aims to (1) define the developmental timing of alcohol-induced alterations in fractalkine signaling, and (2) determine the impact of these changes on...
The University of Colorado-Denver has been awarded a $179,154 Project Grant from the National Institute on Alcohol Abuse and Alcoholism (NIAAA) under the Alcohol Research Programs (CFDA 93.273) grant program. The funding will support research to elucidate the role of Wnt ligands and related signaling pathways in driving the activation of hepatic stellate cells, which are key mediators of liver fibrosis in alcohol-related liver disease. The 2-year project aims to characterize the impact of...